These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11012098)

  • 21. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?
    Testa R; Valente U; Risso D; Caglieris S; Giannini E; Fasoli A; Botta F; Dardano G; Lantieri PB; Celle G
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):559-63. PubMed ID: 10755262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV; Edwards R; Ho S; Lau WY; Glazer G
    Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules.
    Fabris C; Falleti E; Pirisi M; Soardo G; Toniutto P; Vitulli D; Bortolotti N; Gonano F; Bartoli E
    Clin Chim Acta; 1995 Dec; 243(1):25-33. PubMed ID: 8747511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum apoprotein A-I and A-II levels in liver diseases and cholestasis.
    Fujii S; Koga S; Shono T; Yamamoto K; Ibayashi H
    Clin Chim Acta; 1981 Sep; 115(3):321-31. PubMed ID: 6271423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
    Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
    Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
    Imaeda T; Doi H
    J Gastroenterol Hepatol; 1992; 7(2):132-5. PubMed ID: 1373964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma.
    Port GZ; Oliveira K; Soldera J; Tovo CV
    Arq Gastroenterol; 2014; 51(1):10-5. PubMed ID: 24760057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
    Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II.
    Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Okada M
    Cancer Radiother; 2021 May; 25(3):242-248. PubMed ID: 33455875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
    Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis.
    Gramenzi A; Andreone P; Fiorino S; Cammà C; Giunta M; Magalotti D; Cursaro C; Calabrese C; Arienti V; Rossi C; Di Febo G; Zoli M; Craxì A; Gasbarrini G; Bernardi M
    Gut; 2001 Jun; 48(6):843-8. PubMed ID: 11358906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
    Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
    J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-1-fetoprotein and the heat stable alkaline phosphatase in some liver diseases.
    Zizkovský V; Kordac V; Stĕpán J; El'gort DN
    Acta Hepatogastroenterol (Stuttg); 1975 Apr; 22(2):92-7. PubMed ID: 48325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.